Cytokinetics, Inc. (CYTK)
73.77
+0.15
(+0.20%)
USD |
NASDAQ |
Sep 11, 16:00
73.77
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Market Cap : 10.24B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 10.24B |
| September 10, 2026 | 10.22B |
| September 09, 2026 | 10.28B |
| September 08, 2026 | 10.46B |
| September 04, 2026 | 10.09B |
| September 03, 2026 | 10.26B |
| September 02, 2026 | 9.981B |
| September 01, 2026 | 9.908B |
| August 31, 2026 | 9.840B |
| August 28, 2026 | 10.00B |
| August 27, 2026 | 10.81B |
| August 26, 2026 | 10.99B |
| August 25, 2026 | 10.75B |
| August 24, 2026 | 10.70B |
| August 21, 2026 | 10.66B |
| August 20, 2026 | 10.71B |
| August 19, 2026 | 10.79B |
| August 18, 2026 | 10.56B |
| August 17, 2026 | 10.53B |
| August 14, 2026 | 10.29B |
| August 13, 2026 | 10.19B |
| August 12, 2026 | 10.50B |
| August 11, 2026 | 10.61B |
| August 10, 2026 | 10.75B |
| August 07, 2026 | 10.65B |
| Date | Value |
|---|---|
| August 06, 2026 | 11.29B |
| August 05, 2026 | 10.94B |
| August 04, 2026 | 10.91B |
| August 03, 2026 | 9.498B |
| July 31, 2026 | 9.582B |
| July 30, 2026 | 9.991B |
| July 29, 2026 | 9.738B |
| July 28, 2026 | 9.871B |
| July 27, 2026 | 10.02B |
| July 24, 2026 | 10.03B |
| July 23, 2026 | 10.18B |
| July 22, 2026 | 10.21B |
| July 21, 2026 | 10.08B |
| July 20, 2026 | 9.828B |
| July 17, 2026 | 9.961B |
| July 16, 2026 | 9.984B |
| July 15, 2026 | 10.26B |
| July 14, 2026 | 10.18B |
| July 13, 2026 | 10.22B |
| July 10, 2026 | 10.54B |
| July 09, 2026 | 10.69B |
| July 08, 2026 | 10.55B |
| July 07, 2026 | 10.63B |
| July 06, 2026 | 10.63B |
| July 02, 2026 | 10.75B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 130.02B |
| Krystal Biotech, Inc. | 10.27B |
| Ionis Pharmaceuticals, Inc. | 8.979B |
| Vertex Pharmaceuticals, Inc. | 130.59B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
Market Cap Related Metrics
| PS Ratio | 135.66 |
| PEG Ratio | -0.2489 |
| Price | 73.77 |
| Earnings Yield | -9.79% |
| PEGY Ratio | -0.2489 |